Home » Topics » Regulatory » Patents

Patents
RSS

Sanofi presents new Met inhibitors

Nov. 2, 2011

Actelion Pharmaceuticals discloses novel antibacterials

Nov. 2, 2011

New HIV integrase inhibitors presented by Critical Outcome Technologies

Nov. 2, 2011

Novel sterol O-acyltransferase 2 inhibitors synthesized in Japan

Nov. 2, 2011

Palobiofarma prepares novel adenosine A2A receptor antagonists

Oct. 31, 2011

Novel diacylglycerol O-acyltransferase type 1 inhibitors synthesized by AstraZeneca

Oct. 31, 2011

Novel tachykinin NK3 receptor antagonists claimed by Euroscreen

Oct. 31, 2011

Eli Lilly discloses new cannabinoid CB2 receptor agonists

Oct. 31, 2011

Novel transient receptor potential TRPV4 channel antagonists prepared by GSK

Oct. 31, 2011

Researchers at Abbott claim novel inhibitors of Bcl-2

Oct. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...